April showers may bring May flowers to the market, but the median was down a smidgen (0.59%) last week.
Despite it being Spring, WINTER is in the lead.
But what ‘s that old Wall Street slogan, “Sell in May, then go away?”
Apparently it comes from Merry Olde England:
thestreet.com
I don’t think it applies anymore, or at least I hope not, as the FDA is still playing catch up with some PDUFA dates. The pandemic threw a monkey wrench into almost everyone’s idea of “normal.”
No astonishing gains this week, but SUPN is up 12%, on top of being up 5 or 10% the week before after the FDA approved their drug for ADHD two weeks ago. I’m not sure why it took an additional week for the news to sink in, but perhaps the traders were too hyper to pay attention.
“Unlike nearly all other ADHD medicines, Qelbree is not a stimulant or a controlled substance, making it harder to abuse than older drugs. That’s been a problem with earlier ADHD treatments like Ritalin, nearly all of which contain the stimulants amphetamine or methylphenidate.”
BIOSCI has the unusual distinction of having a stock on both the weeks biggest gainers list and biggest losers list simultaneously, with their two picks on the Hong Kong market moving in opposite directions.
Wisely, they put 12% of their portfolio in 1099.HK, which was up, and only 8% into 6185.HK, which was down.
|
Report Time Ranges
|
|
|
From
|
To
|
Recent
|
4/9/21
|
4/16/2021
|
YTD
|
12/31/2020
|
Index Performance
|
|
Symbol
|
Recent
|
YTD
|
|
^IXIC
|
1.09%
|
9.03%
|
^NBI
|
3.18%
|
1.27%
|
^SPSIBI
|
1.16%
|
-6.69%
|
Share Performance
|
Recent
|
YTD
|
Top 5
|
Bottom 5
|
Top 5
|
Bottom 5
|
INMB
|
15.718%
|
ADXS
|
-29.590%
|
PAND
|
304.38%
|
FREQ
|
-72.80%
|
CLNK-B.ST
|
15.248%
|
PULM
|
-24.829%
|
ANVS
|
185.81%
|
OTIC
|
-65.84%
|
HROW
|
13.475%
|
ONCT
|
-21.550%
|
ANCN
|
172.25%
|
CNCE
|
-65.11%
|
SUPN
|
11.975%
|
BBI
|
-20.368%
|
PDSB
|
151.87%
|
ACAD
|
-60.44%
|
1099.HK
|
11.740%
|
6185.HK
|
-19.942%
|
DVAX
|
146.97%
|
SRPT
|
-57.89%
|
Top 10 Portfolio Performance YTD
|
|
WINTER
|
41.85%
|
|
BMAZ
|
39.52%
|
DNAJOE
|
36.52%
|
ERIK
|
31.16%
|
MASTER
|
26.03%
|
TWONE
|
20.77%
|
DANIEL
|
15.25%
|
OHMS
|
13.26%
|
OLIVER
|
11.44%
|
SQUARE
|
11.42%
|
Average and Median Portfolio Performance
|
|
Avg Recent
|
Avg YTD
|
Median Recent
|
Median YTD
|
|
-$6715.87
|
1.53%
|
JACKH
|
-$5637.38
|
JACKH
|
-0.59%
|
-5.988%
|
BIOADD
|
-4.923%
|
|
